1. Home
  2. CRWS vs EVAX Comparison

CRWS vs EVAX Comparison

Compare CRWS & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.78

Market Cap

29.4M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.64

Market Cap

30.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
EVAX
Founded
1957
2008
Country
United States
Denmark
Employees
N/A
46
Industry
Textiles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
30.4M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CRWS
EVAX
Price
$2.78
$3.64
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
38.6K
29.4K
Earning Date
02-11-2026
05-07-2026
Dividend Yield
11.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
6.51
N/A
52 Week Low
$2.35
$2.11
52 Week High
$3.17
$12.15

Technical Indicators

Market Signals
Indicator
CRWS
EVAX
Relative Strength Index (RSI) 49.99 42.55
Support Level $2.69 $3.35
Resistance Level $2.92 $4.57
Average True Range (ATR) 0.09 0.27
MACD -0.00 -0.03
Stochastic Oscillator 41.96 27.19

Price Performance

Historical Comparison
CRWS
EVAX

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: